Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.4M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
+139K
-
Total reported value, excl. options
-
$566M
-
Value change
-
+$3.22M
-
Number of buys
-
24
-
Number of sells
-
-16
-
Price
-
$25.82
Significant Holders of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) as of Q1 2020
50 filings reported holding PHAT - Phathom Pharmaceuticals, Inc. - Common Stock as of Q1 2020.
Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
of 71.4M outstanding shares and own 30.76% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (7.28M shares), RA CAPITAL MANAGEMENT, L.P. (3.71M shares), Invesco Ltd. (2.08M shares), Medicxi Ventures Management (Jersey) Ltd (2.07M shares), JANUS HENDERSON GROUP PLC (1.67M shares), Abingworth LLP (1.2M shares), BVF INC/IL (677K shares), Ensign Peak Advisors, Inc (597K shares), BlackRock Inc. (585K shares), and EVENTIDE ASSET MANAGEMENT, LLC (450K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.